Prognosis of Early-onset Anorexia Nervosa

Recruiting now

Conditions studied: Anorexia Nervosa

In brief

The AM2P study aims to evaluate the long-term prognosis and quality of life of patients with early-onset anorexia nervosa, assessed 4 to 9 years after hospitalization. Prognosis will be determined using a composite outcome measure based on questionnaire responses and health indicators, including body mass index (BMI). In addition, the study will examine the patients' overall physical condition both at the time of assessment and during the interval between their last hospitalization and the present evaluation.

Key facts

Study ID

NCT07311356

Run by

Assistance Publique - Hôpitaux de Paris

People needed

140

Starts

2025-12-05

Expected to finish

2026-03-31

Last updated by the study team

2026-02-03

Who can join

Age: any, up to 30. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• First full hospitalization in the eating disorders unit (EDU) at Robert Debré Hospital and diagnosis of AMP from 2016 to 2021
• No objection from the minor to the study
• Proficiency and understanding of the French language
• Access to digital technology (computer, smartphone, tablet, etc.)

You may not qualify if…

• Primary diagnosis of ARFID, other unspecified eating disorder

Where it is running

• Hopital Robert Debre - AP-HP — Paris, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.